Prevalence and Predictors of Urinary Tract Infections among Children with Cerebral Palsy in Makurdi, Nigeria

Table 3

Urinary culture and sensitivity patterns among subjects with cerebral palsy and controls without cerebral palsy.

	CP					NO CP
	E. coli	Strept. faecalis	Staph. aureus	Proteus spp.	Klebsiella spp.	E. coli
No. of Significant growth	9	4	3	2	2	2
Sensitivity
Ciprofloxacin	9 (100%)	4 (100%)	3 (100%)	2 (100%)	2 (100%)	2 (100%)
Ofloxacin	9 (100%)	4 (100%)	3 (100%)	2 (100%)	2 (100%)	2 (100%)
Sparfloxacin	9 (100%)	4 (100%)	3 (100%)	2 (100%)	2 (100%)	2 (100%)
Ceftriazone	9 (100%)	4 (100%)	3 (100%)	2 (100%)	2 (100%)	2 (100%)
Gentamycin	6 (66.7%)	4 (75%)	1 (33.3%)	1 (50%)	1 (50%)	1 (50%)
Nalidixic acid	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)
Streptomycin	5 (55.6%)	2 (50%)	1 (33.3%)	1 (50%)	1 (50%)	1 (50%)
Amoxiclav	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)
Tetracycline	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)
Cotrimoxazole	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)
Nitrofuratoin	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)

CP: Subjects with cerebral palsy, NO CP: Controls without cerebral palsy, E. coli: Escherichia coli, Staph. aureus: Staphylococcus aureus, Strept. faecalis: Streptococcus faecalis.